Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Breast Diseases × Drug Evaluation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 2 Breast Neoplasms 2 Basal Cell Nevus Syndrome 2 Thrombocythemia, Essential 1 Polycythemia Vera 1 Hypogonadism 1 Glioma 1 Fatigue Syndrome, Chronic 1 Eunuchism 1 Colorectal Neoplasms 1 Breast Diseases 1

Interventions

pyrotinib 2 Trastuzumab 2 Letrozole 2 Docetaxel 2 figitumumab 1 exemestane 1 Zoledronic Acid 1 Vinorelbine 1 Lapatinib 1 Everolimus 1 Drug Evaluation 1 Cyclophosphamide 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03910712 2019-04-10

Pyrotinib

Peking Union Medical College Hospital

Phase 2 Unknown

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡